Literature DB >> 8509984

The risk of tropical spastic paraparesis differs according to ethnic group among HTLV-I carriers in Inongo, Zaire.

D Jeannel1, B Garin, K Kazadi, L Singa, G de Thé.   

Abstract

Following the finding in 1990 of six HTLV-I-positive cases of tropical spastic paraparesis (TSP/HAM) is a field survey carried out in the city of Inongo (Bandundu, Zaire), the prevalence of HTLV-I infection has been studied by detection of specific antibodies on a randomized sample of the general population. Among the 1,162 subjects surveyed, 36 (3.1%) were found to be HTLV-I seropositive, giving a seroprevalence of 3.2% (CI: 2.1, 4.3) estimated by direct standardization on age and sex distribution given by the census in the city. Among the five major ethnic groups, the Bolia showed the highest prevalence rate (6.5%) but with no detected TSP/HAM cases, while all six TSP/HAM cases were found among the Ntomba, who showed a prevalence rate of only 2.2%. This finding suggests that besides HTLV-I infection, critical environmental and/or genetic cofactors play a part in the development of TSP/HAM.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509984

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  9 in total

Review 1.  Pathogenesis and treatment of HTLV-I associated myelopathy.

Authors:  G P Taylor
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

2.  Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies.

Authors:  R Mahieux; F Ibrahim; P Mauclere; V Herve; P Michel; F Tekaia; C Chappey; B Garin; E Van Der Ryst; B Guillemain; E Ledru; E Delaporte; G de The; A Gessain
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 3.  Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease.

Authors:  H B Urnovitz; W H Murphy
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

4.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

5.  Editorial Commentary: Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) and HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.

Authors:  Graham P Taylor
Journal:  Clin Infect Dis       Date:  2015-03-27       Impact factor: 9.079

6.  Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure.

Authors:  Megan Halbrook; Adva Gadoth; Anupama Shankar; HaoQiang Zheng; Ellsworth M Campbell; Nicole A Hoff; Jean-Jacques Muyembe; Emile Okitolonda Wemakoy; Anne W Rimoin; William M Switzer
Journal:  PLoS Negl Trop Dis       Date:  2021-01-28

Review 7.  A global perspective on the influence of environmental exposures on the nervous system.

Authors:  Desire Tshala-Katumbay; Jean-Claude Mwanza; Diane S Rohlman; Gladys Maestre; Reinaldo B Oriá
Journal:  Nature       Date:  2015-11-19       Impact factor: 49.962

Review 8.  Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa.

Authors:  James M Fox; Nora Mutalima; Elizabeth Molyneux; Lucy M Carpenter; Graham P Taylor; Martin Bland; Robert Newton; Fabiola Martin
Journal:  Trop Med Int Health       Date:  2016-02-03       Impact factor: 2.622

9.  Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1).

Authors:  Yoshimi Enose-Akahata; Breanna Caruso; Benjamin Haner; Emily Charlip; Govind Nair; Raya Massoud; Bridgette J Billioux; Joan Ohayon; William M Switzer; Steven Jacobson
Journal:  Retrovirology       Date:  2016-08-12       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.